Tucatinib/tucatinib effects and efficacy

Tucatinib/Tucatinib is a kinase inhibitor. Tucatinib is used in combination with trastuzumab and capecitabine to treat patients with advanced unresectable disease. or adult patients with metastatic HER2-positive breast cancer, including patients with brain metastases who have received one or more prior anti-HER2-based regimens in the setting of metastasis. Tucatinib is indicated in combination with trastuzumab for the treatment of adult patients with RAS wild-type HER2-positive unresectable or metastatic colorectal cancer that has progressed after treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.

Results from a trial showed that the risk of progression or death was 46% lower in the tucatinib plus trastuzumab and capecitabine group than in the placebo group at 1 year of follow-up. Mutations in the HER-2 gene are seen in some types of breast cancer. Tucatinib inhibits the tyrosine kinase of the HER-2 gene. Mutations in the tyrosine kinase HER-2 gene lead to a cascade of increased cell signaling and proliferation, leading to malignancy. In vitro study results show that tucatinib inhibits the phosphorylation of HER-2 and HER-3, leading to downstream changes in MAPK and AKT signaling and cell proliferation. Cells expressing HER-2 have anti-tumor activity. In vivo, tucatinib may inhibit HER-2-expressing tumors by the same mechanism. There is a generic version of this drug in Bangladesh. The retail price of Everest Pharmaceuticals in Bangladesh is about 150mg30 tablets6000 yuan. The retail price of Ziska Pharmaceuticals in Bangladesh is around 4,500 yuan for 150 mg 30 tablets. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.